398 related articles for article (PubMed ID: 18051893)
1. [Freeze-drying of oleanolic acid-loaded nanosuspensions].
Zhao XL; Chen HB; Chen YJ; Yang XL
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1874-6. PubMed ID: 18051893
[TBL] [Abstract][Full Text] [Related]
2. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
3. Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles.
Fonte P; Soares S; Sousa F; Costa A; Seabra V; Reis S; Sarmento B
Biomacromolecules; 2014 Oct; 15(10):3753-65. PubMed ID: 25180545
[TBL] [Abstract][Full Text] [Related]
4. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying.
Doktorovova S; Shegokar R; Fernandes L; Martins-Lopes P; Silva AM; Müller RH; Souto EB
Pharm Dev Technol; 2014 Dec; 19(8):922-9. PubMed ID: 24099511
[TBL] [Abstract][Full Text] [Related]
5. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
6. Study on formability of solid nanosuspensions during solidification: II novel roles of freezing stress and cryoprotectant property.
Yue PF; Li G; Dan JX; Wu ZF; Wang CH; Zhu WF; Yang M
Int J Pharm; 2014 Nov; 475(1-2):35-48. PubMed ID: 25158243
[TBL] [Abstract][Full Text] [Related]
7. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
[TBL] [Abstract][Full Text] [Related]
8. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
9. Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying.
Ma X; Santiago N; Chen YS; Chaudhary K; Milstein SJ; Baughman RA
J Drug Target; 1994; 2(1):9-21. PubMed ID: 8069587
[TBL] [Abstract][Full Text] [Related]
10. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design.
Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Dehkordi AJ; Kobarfard F
Pharm Dev Technol; 2012; 17(2):187-94. PubMed ID: 21047276
[TBL] [Abstract][Full Text] [Related]
11. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
Abdelwahed W; Degobert G; Fessi H
Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
[TBL] [Abstract][Full Text] [Related]
13. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
14. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers.
Wang L; Ma Y; Gu Y; Liu Y; Zhao J; Yan B; Wang Y
J Microencapsul; 2018 May; 35(3):241-248. PubMed ID: 29624090
[TBL] [Abstract][Full Text] [Related]
15. Freeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distribution.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 May; 100(5):1958-68. PubMed ID: 21374626
[TBL] [Abstract][Full Text] [Related]
16. Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.
Lee MK; Kim MY; Kim S; Lee J
J Pharm Sci; 2009 Dec; 98(12):4808-17. PubMed ID: 19475555
[TBL] [Abstract][Full Text] [Related]
17. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
[TBL] [Abstract][Full Text] [Related]
18. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
[TBL] [Abstract][Full Text] [Related]
19. Process optimization of a novel production method for nanosuspensions using design of experiments (DoE).
Salazar J; Heinzerling O; Müller RH; Möschwitzer JP
Int J Pharm; 2011 Nov; 420(2):395-403. PubMed ID: 21925582
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
